Sumitomo Pharma Co. Ltd
Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson's disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, an… Read more
Sumitomo Pharma Co. Ltd - Asset Resilience Ratio
Sumitomo Pharma Co. Ltd (SMDPY) has an Asset Resilience Ratio of 2.27% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2005–2025)
This chart shows how Sumitomo Pharma Co. Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Sumitomo Pharma Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $16.84 Billion | 2.27% |
| Total Liquid Assets | $16.84 Billion | 2.27% |
Asset Resilience Insights
- Limited Liquidity: Sumitomo Pharma Co. Ltd maintains only 2.27% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Sumitomo Pharma Co. Ltd Industry Peers by Asset Resilience Ratio
Compare Sumitomo Pharma Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Biostar Pharmaceuticals Inc
PINK:BSPM |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
High Sierra Technologies Inc
PINK:HSTI |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
Drug Manufacturers - Specialty & Generic | 20.44% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
Annual Asset Resilience Ratio for Sumitomo Pharma Co. Ltd (2005–2025)
The table below shows the annual Asset Resilience Ratio data for Sumitomo Pharma Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 2.27% | $16.84 Billion | $742.60 Billion | +1.49pp |
| 2024-03-31 | 0.78% | $7.08 Billion | $907.51 Billion | -1.00pp |
| 2023-03-31 | 1.78% | $20.17 Billion | $1.13 Trillion | -0.94pp |
| 2022-03-31 | 2.72% | $35.60 Billion | $1.31 Trillion | +0.47pp |
| 2021-03-31 | 2.25% | $29.48 Billion | $1.31 Trillion | -0.04pp |
| 2020-03-31 | 2.29% | $28.72 Billion | $1.25 Trillion | -2.95pp |
| 2019-03-31 | 5.24% | $43.75 Billion | $834.72 Billion | +2.52pp |
| 2018-03-31 | 2.73% | $22.07 Billion | $809.68 Billion | -1.58pp |
| 2017-03-31 | 4.31% | $34.20 Billion | $793.95 Billion | -7.14pp |
| 2016-03-31 | 11.45% | $81.04 Billion | $707.71 Billion | -4.19pp |
| 2015-03-31 | 15.64% | $111.29 Billion | $711.58 Billion | +3.20pp |
| 2014-03-31 | 12.44% | $81.95 Billion | $659.03 Billion | -1.80pp |
| 2013-03-31 | 14.24% | $86.46 Billion | $607.22 Billion | -3.48pp |
| 2012-03-31 | 17.72% | $99.12 Billion | $559.41 Billion | +2.30pp |
| 2011-03-31 | 15.41% | $90.92 Billion | $589.87 Billion | +7.25pp |
| 2010-03-31 | 8.17% | $51.18 Billion | $626.74 Billion | -0.65pp |
| 2009-03-31 | 8.82% | $34.50 Billion | $391.29 Billion | +1.29pp |
| 2008-03-31 | 7.53% | $30.09 Billion | $399.79 Billion | +0.22pp |
| 2007-03-31 | 7.31% | $27.96 Billion | $382.54 Billion | +3.75pp |
| 2006-03-31 | 3.56% | $13.99 Billion | $392.97 Billion | +1.32pp |
| 2005-03-31 | 2.24% | $4.51 Billion | $201.43 Billion | -- |